Inorganic phosphate and the risk of cancer in the Swedish AMORIS study

Abstract

BackgroundBoth dietary and serum levels of inorganic phosphate (Pi) have been linked to development of cancer in experimental studies. This is the first population-based study investigating the relation between serum Pi and risk of cancer in humans.MethodsFrom the Swedish Apolipoprotein Mortality Risk (AMORIS) study, we selected all participants (> 20 years old) with baseline measurements of serum Pi, calcium, alkaline phosphatase, glucose, and creatinine (n = 397,292). Multivariable Cox proportional hazards regression analyses were used to assess serum Pi in relation to overall cancer risk. Similar analyses were performed for specific cancer sites.ResultsWe found a higher overall cancer risk with increasing Pi levels in men ( HR: 1.02 (95% CI: 1.00-1.04) for every SD increase in Pi), and a negative association in women (HR: 0.97 (95% CI: 0.96-0.99) for every SD increase in Pi). Further analyses for specific cancer sites showed a positive link between Pi quartiles and the risk of cancer of the pancreas, lung, thyroid gland and bone in men, and cancer of the oesophagus, lung, and nonmelanoma skin cancer in women. Conversely, the risks for developing breast and endometrial cancer as well as other endocrine cancer in both men and women were lower in those with higher Pi levels.ConclusionsAbnormal Pi levels are related to development of cancer. Furthermore, the in verse association between Pi levels and risk of breast, endometrial and other endocrine cancers may indicate the role of hormonal factors in the relation between Pi metabolism and cancer.

HMGA1 Drives Metabolic Reprogramming of Intestinal Epithelium during Hyperproliferation, Polyposis, and Colorectal Carcinogenesis

“…Further studies are needed to dissect the role of inorganic phosphates in abnormal proliferation, polyposis, CRC and HMGA1. 62 We found several metabolites that differentiate the Hmga1 transgenic intestine from controls, but did not distinguish human CRC samples from nonmalignant tissues. It is possible that these metabolites are required only for early proliferative stages in carcinogenesis, but not for more advanced disease or frank carcinomas.…”

The Phosphate Content of Prescription Medication: A New Consideration

“…10,11 For example, a high dietary phosphate is associated with increased cancer cell proliferation in animals 12 and humans. 13 If alternative agents of similar safety, effectiveness, and cost are available, they could be substituted for high-phosphate medications. Such a strategy might be appropriate for many ''high risk'' drugs, such as lisinopril, bisoprolol, and amlodipine.…”

1009 Serum lactate dehydrogenase and survival following cancer diagnosis

“…We calculated Charlson comorbidity index (CCI) using information from the National Patient Register. The CCI consists of 17 groups of diseases with a specific weight assigned to each disease category (Wulaningsih et al, 2013a). These weights were then summed to obtain an overall score, resulting in four comorbidity levels (0, 1, 2 and 3 þ ) indicating no comorbidity to severe comorbidity.…”